ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CGEN Compugen Ltd

1.92
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:32:01
15분 지연
기업명 주식 심볼 시장 주식 타입
Compugen Ltd CGEN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.92 20:32:01
개장가 저가 고가 종가 전일 종가
1.92
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00PRNUSCompugen to Present New Clinical Data Showing COM701 Triple..
10/04/202420:00PRNUSCompugen Publishes Paper in Cancer Immunology Research..
03/04/202420:00PRNUSCompugen to Participate in Two Upcoming Investor Conferences
11/03/202420:00PRNUSCompugen Selected for two Oral Presentations at the Keystone..
06/03/202421:00PRNUSCompugen to Present Data Reflecting its Diversified..
06/03/202406:06EDGAR2Form 20-F - Annual and transition report of foreign private..
05/03/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/03/202421:00PRNUSCompugen Reports Fourth Quarter and Full Year 2023 Results
05/03/202420:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
26/02/202421:00PRNUSCompugen to Present at the Leerink Partners Global Biopharma..
20/02/202421:00PRNUSCompugen to Release Fourth Quarter and Full Year 2023..
15/02/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202421:00PRNUSCompugen Announces Appointment of Michelle Mahler M.D. as..
08/01/202421:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202421:05PRNUSCompugen to Receive $10 Million Milestone Payment Following..
08/01/202421:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
19/12/202323:30APSStrong Open For Biotech Following Exclusive Agreement..
19/12/202321:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202321:10PRNUSCompugen will be Eligible to Receive $10 Million Milestone..
19/12/202321:05PRNUSCompugen to Host Conference Call to Discuss Exclusive..
19/12/202321:00BWGilead and Compugen Announce Exclusive License Agreement for..
07/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202321:00PRNUSCompugen Reports Third Quarter 2023 Results
06/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202321:00PRNUSCompugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity..
04/11/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202305:35PRNUSCompugen Announces Receipt of Nasdaq Minimum Bid Price..
31/10/202322:00PRNUSCompugen to Present New Data at SITC 2023 Suggesting Leading..
24/10/202320:00PRNUSCompugen to Release Third Quarter 2023 Results on Tuesday,..
03/10/202320:00PRNUSCompugen to Present at Single Cell Genomics 2023 Meeting
02/10/202320:00PRNUSCompugen Expands Intellectual Property with New Japanese..
27/09/202322:00PRNUSCompugen to Present New Clinical and Pre-Clinical Data in..
21/09/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/08/202320:00PRNUSCompugen to Present at the H.C. Wainwright 25th Annual..
23/08/202321:00EDGAR2Form 20-F/A - Annual and transition report of foreign..
07/08/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/08/202320:00PRNUSCompugen Reports Second Quarter 2023 Results
24/07/202320:00PRNUSCompugen to Release Second Quarter 2023 Results on Monday,..
17/07/202320:00PRNUSCompugen Wins on PVRIG European Patent Opposition Pursued by..
22/06/202320:00PRNUSCompugen Doses First Patient in Triple Immunotherapy..
13/06/202320:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
05/06/202320:00PRNUSCompugen's COM701 (anti-PVRIG) Demonstrates Preliminary..
15/05/202320:00PRNUSCompugen Reports First Quarter 2023 Results
11/05/202320:00PRNUSCompugen to Host DNAM-1 Axis Virtual Investor Event with KOL..
09/05/202320:00PRNUSCompugen to Present at the JMP Securities Life Sciences..
01/05/202320:00PRNUSCompugen to Release First Quarter 2023 Results on Monday,..

최근 히스토리

Delayed Upgrade Clock